Ticker Details
Medicinova Inc MediciNova Inc is a biopharmaceutical company. It is engaged in acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs.
IPO Date:	December 7, 2006
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$73.72M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.12 | 2.67%
Avg Daily Range (30 D):	$0.05 | 3.15%
Avg Daily Range (90 D):	$0.04 | 2.80%

Institutional Daily Volume
Avg Daily Volume:	.13M
Avg Daily Volume (30 D):	.07M
Avg Daily Volume (90 D):	.68M

Trade Size
Avg Trade Size (Sh.):	177
Avg Trade Size (Sh.) (30 D):	179
Avg Trade Size (Sh.) (90 D):	265

Institutional Trades
Total Institutional Trades:	59
Avg Institutional Trade:	$1.84M
Avg Institutional Trade (30 D):	$.57M
Avg Institutional Trade (90 D):	$.55M
Avg Institutional Trade Volume:	.29M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.19M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	538.88K

News

Jan 29, 2026 @ 11:00 PM MediciNova Announces 100 Patients Enrolled in SEAN... Source: Medicinova, Inc.

Dec 8, 2025 @ 11:00 AM MediciNova Announces Update and Basic Characterist... Source: Medicinova, Inc.

Dec 1, 2025 @ 11:00 PM Message from the CEO to MediciNova Shareholders Source: Yuichi Iwaki, M.D., Ph.D.

Nov 6, 2025 @ 11:00 PM MediciNova Wins Contract Research and Development ... Source: Medicinova, Inc.

Aug 26, 2025 @ 11:00 PM MediciNova Achieves Enrollment in COMBAT-ALS Clini... Source: Dr. Yuichi Iwaki

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$-.06	$-.07
Diluted EPS		$-.06	$-.07
Revenue		$.12M	$.13M
Gross Profit
Net Income / Loss		$-3.05M	$-3.28M
Operating Income / Loss		$-3.38M	$-3.61M
Cost of Revenue
Net Cash Flow		$6.09M	$-2.31M
PE Ratio

Splits
Oct 31, 2006	1:10